nm23-H1 expression and loss of heterozygosity in colon adenocarcinoma

Journal of Clinical Pathology

Volumn 57, Issue 12, 2004, Pages 1312-1318

  Kapitanovic S ^a   Cacev T ^a   Berkovic M ^a   Popovic Hadzija M ^a   Radosevic S ^b   Seiwerth, S ^c   Spaventi, S ^d   Pavelic K ^a   Spaventi, R ^b  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b PLIVA CROATIA LTD   (Croatia)

^c UNIVERSITY OF ZAGREB   (Croatia)

^d CROATIAN ACADEMY OF SCIENCES AND ARTS   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; NUCLEOSIDE DIPHOSPHATE KINASE A; ONCOPROTEIN; PARAFFIN;

5' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; COLON ADENOCARCINOMA; CONTROLLED STUDY; DNA DETERMINATION; EVALUATION; FEMALE; GENE EXPRESSION REGULATION; GENE LOCATION; GENETIC DISORDER; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA GENE; TISSUE SECTION; UNTRANSLATED REGION; VARIABLE NUMBER OF TANDEM REPEAT;

ADENOCARCINOMA; AGED; COLONIC NEOPLASMS; DNA, NEOPLASM; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOHISTOCHEMISTRY; LOSS OF HETEROZYGOSITY; MALE; NEOPLASM STAGING; NUCLEOSIDE-DIPHOSPHATE KINASE; POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 10044228613     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2004.017954     Document Type: Article

References (44)

1. Wang L, Patel U, Ghosh L, et al. Mutation in the nm23 gene is associated with metastasis in colorectal cancer. Cancer Res 1993;53:717-20.
2. MacDonald NJ, De la Rosa A, Steeg PS. The potential roles of nm23 in cancer metastasis and cellular differentiation. Eur J Cancer 1995;31A:1096-100.
3. Heide I, Thiede C, Poppe K, et al. Expression and mutational analysis of nm23-H1 in liver metastases of colorectal cancer. Br J Cancer 1994;70:1267-71.
4. Steeg PS, Bevilacqua G, Kopper L, et al. Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst 1988;80:200-4.
5. Stahl JA, Leone A, Rosengard AM, et al. Identification of a second human nm23 gene, nm23-H2. Concertes 1991;51:445-9.
6. MacDonald NJ, De la Rosa A, Benedict MA, et al. A serine phosphorylation of nm23, and not its nucleaside diphosphate kinase activity, correlates with suppression of tumor metastatic potential. J Biol Chem 1993;268:25780-9.
7. Freije JM, Blay P, MacDonald NJ, et al. Site-directed mutation of nm23-H1. Mutations lacking motility suppressive capacity upon transfection are deficient in histidine-dependent protein phosphotransferase pathways in vitro. J Biol Chem 1997;272:5525-32.
8. De la Rosa A, Williams RL, Steeg PS. Nm23/nucleoside diphosphate kinase: toward a structural and biochemical understanding of its biological functions. Bioessays 1995;17:53-62.
9. Pavelić K, Kapitanović S, Radošević S, et al. Increased activity of nm23-H1 gene in squamous cell carcinoma of the head and neck is associated with advanced disease and poor prognosis. J Mol Med 2000;78:111-18.
10. Yamaguchi A, Urana T, Fushida S, et al. Inverse association of nm23-H1 expression by colorectal cancer with liver metastasis. Cancer 1993;68:1020-4.
11. Martinez JA, Prevot S, Nordlinger B, et al. Overexpression of nm23-H1 and nm23-H2 genes in colorectal carcinomas and loss of nm23-H1 expression in advanced tumour stages. Gut 1995;37:712-20.
12. Tannapfel A, Kockerling F, Katalinic A, et al. Expression of nm23-H1 predicts lymph node involvement in colorectal carcinoma. Dis Colon Rectum 1995;38:651-4.
13. Royds JA, Cross SS, Silcocks PB, et al. Nm23 "anti-metastatic" gene product expression in colorectal carcinoma. J Pathol 1994;172:261-6.
14. Lindmark G. Nm23-H1 immunohistochemistry is not useful as predictor of metastatic potential of colorectal cancer. Br J Cancer 1996;74:1413-18.
15. Indinnimeo M, Cicchini C, Stazi A, et al. Correlation between nm23-H1 overexpression and clinicopothological variables in human anal canal carcinoma. Oncol Rep 1999;6:1353-6.
16. Cohn KH, Wang FS, Desoto-LaPaix F, et al. Association of nm23-H1 allelic deletions with distant metastases in colorectal carcinoma. Lancet 1991;338:722-4.
17. Leone A, McBride OW, Weston A, et al. Somatic allelic deletion of nm23 in human cancer. Cancer Res 1991;51:2490-3.
18. Cohn KH, Ornstein DL, Wang F, et al. The significance of allelic deletions and aneuploidy in colorectal carcinoma. Cancer 1997;79:233-44.
19. Myeroff LL, Markowitz SD. Increased nm23-H1 and nm23-H2 messenger RNA expression and absence of mutations in colon carcinomas of low and high metastatic potential. J Natl Cancer Inst 1993;85:147-52.
20. Cawkwell L, Lewis FA, Quirke P. Frequency of allele loss of DCC, p53, RB1, WT1, NF1, NM23, APC/MCC in colorectal cancer assayed by fluorescent multiplex polymerase chain reaction. Br J Cancer 1994;70:813-18.
21. Spaventi R, Pečur L, Pavelić K, et al. Human tumor bank in Croatia: a possible model for a small bank as a port of the future European tumor bank network. Eur J Cancer 1994;30A:419.
22. Turnubull RB, Kyle K, Watson FR, et al. Cancer of the rectum: the influence of the no-touch isolation technique on survival rates. Ann Surg 1967;166:420-7.
23. Deans GT, Parks TG, Rowlands BJ, et al. Prognostic factors in colorectal cancer. Br J Surg 1992;79:608-13.
24. Herak Bosnar M, Pavelić K, Hrašćan R, et al. Loss of heterozygosity of the nm23-H1 gene in human renal cell carcinomas. J Cancer Res Clin Oncol 1997;123:485-8.
25. Ljungberg B, Osterdahl B, Mehle C. Clinical significance of nm23 expression in renal cell carcinoma. Urol Res 1999;27:103-7.
26. Tomita M, Ayabe T, Matsuzaki Y, et al. Expression of nm23-H1 gene product in esophageal squamous cell carcinoma and its association with vessel invasion and survival. BMC Cancer 2001;1:3-7.
27. Müller W, Schneiders A, Hommel G, et al. Expression of nm23 in gastric carcinoma. Cancer 1998;83:2481-7.
28. Mao H, Liu H, Fu X, et al. Loss of nm23 expression predicts distal metastases and poorer survival for breast cancer. Int J Oncol 2001;18:587-91.
29. Cheah PY, Cao X, Eu KW, et al. Nm23-H1 immunostaining is inversely associated with tumour staging but not overall survival or disease recurrence in colorectal corcinomas. Br J Cancer 1998;77:1164-8.
30. Volm M, Mattern J, Koomagi R. Association between nm23-H1 expression, proliferation and apoptosis in non-small cell lung carcinomas. Clin Exp Metastasis 1998;16:595-602.
31. Ayhan A, Usubutun A, Ozen H, et al. nm23 protein expression in renal cell tumors: the role of the cell type. Oncol Rep 1998;5:979-83.
32. Schneider J, Pollan M, Jimenez E, et al. nm23-H1 expression defines a high-risk subpopulation of patients with early-stage epithelial ovarian carcinoma. Br J Cancer 2000;82:1662-70.
33. Boekelandt M, Holm R, Trope CG, et al. The significance of metastasis-related factors cathepsin-D and nm23 in advanced ovarian cancer. Ann Oncol 1999;10:1335-41.
34. Iizuka N, Tangoku A, Hayashi H, et al. The association between nm23-H1 expression and survival in patients with esophageal squamous cell carcinoma. Cancer Lett 1999;138:139-44.
35. Sarris M, Konopka M, Lee CS. Differential expression of the nm23 protein in the progression of oesophageal adenocarcinoma. Pathology 2003;35:37-41.
36. Nakamura T, Tabuchi Y, Ohno M. Relations of nm23 expression to clinicopathologic variables and proliferative activity of gastric cancer lesions. Cancer Detect Prev 1998;22:246-50.
37. Nesi G, Palli D, Pernice LM, et al. Expression of nm23 gene in gastric cancer is associated with a poor 5-year survival. Anticancer Res 2001;21:3643-9.
38. Tabuchi Y, Nakamura T, Kuniyasu T, et al. Expression of nm23-H1 in colorectal cancer: no association with metastases, histological stage, or survival. Jpn J Surg 1999;29:116-20.
39. Zeng ZS, Hsu S, Zhang ZF, et al. High level of nm23-H1 gene expression is associated with local colorectal cancer progression not with metastases. Br J Cancer 1994;70:1025-30.
40. Herak Bosnar M, Pavelić K, Križanac Š, et al. Squamous cell lung carcinomas: the role of nm23-H1 gene. J Mol Med 1997;75:609-13.
41. Mandai M, Konishi I, Komatsu T, et al. Mutation of the nm23 gene, loss of heterozygosity at the nm23 locus and K-ras mutation in ovarian carcinoma: correlation with tumor progression and nm23 gene expression. Br J Cancer 1995;72:691-5.
42. Hwang BG, Park IC, Park MJ, et al. Role of the nm23-H1 gene in the metastasis of gastric cancer. J Korean Med Sci 1997;12:514-18.
43. Berney CR, Fisher RJ, Yang JI, et al. Genomic alterations (LOH, MI) on chromosome 17q21-23 and prognosis of sporadic colorectal cancer. Int J Cancer 2000;89:1-7.
44. Okada K, Urano T, Goi T, et al. Isolation of human nm23 genomes and analysis of loss of heterozygosity in primary colorectal carcinomas using a specific genomic probe. Cancer Res 1994;54:3979-82.